Comparison of limbal-conjunctival autograft and intraoperative 0.02% mitomycin-C for treatment of primary pterygium
Tóm tắt
To compare the outcomes of use of intraoperative 0.02% mitomycin-C (MMC) and limbal-conjunctival autograft (LCAG) for treatment of primary pterygia. One hundred and twelve eyes of eighty patients with primary pterygia were randomly treated either by intraoperative 0.02% MMC for 5 min or LCAG. Recurrence (defined as fibrovascular tissue invading the cornea >1.5 mm) and complications were evaluated. Fifty-two eyes were included in the MMC group and sixty in the LCAG group. Recurrence occurred in three eyes (5.76%) in the MMC group and in two eyes (3.33%) in the LCAG group. This difference between recurrence in the two groups was not statistically significant (P > 0.05). Incidence of complications such as conjunctival cysts, symblephara, conjunctival hyperemia, and subconjunctival hemorrhage was similar in both groups (P > 0.05) whereas corneal epithelial defects (CED), irritation, lacrimation, and photophobia were more common in the MMC group (P < 0.05). Simple excision then intraoperative use of 0.02% (MMC) for 5 min or LCAG are similarly successful in the treatment of primary pterygia. Some complications, for example irritation, lacrimation, photophobia, and CED are more common when simple excision is followed by MMC.
Tài liệu tham khảo
Laros PA, Deluise VP (1988) Pingueculae and pterygium. Surv Ophthalmol 33:41–49
Lam DS, Wong AK, Fan DS et al (1998) Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30–month follow-up study. Ophthalmology 105:901–904
Manning CA, Kloess PM, Diaz MD et al (1997) Intraoperative mitomycin C in primary pterygium excision. A controlled randomized trail. Ophthalmology 104:844–848
Mutlu FM, Sobaci G, Tatar T et al (1999) A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap. Ophthalmology 106(4):817–821
Dunn JP, Seamone CD, Ostler HB et al (1991) Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy. Am J Ophthalmol 112(3):343–344
Dougherty PJ, Hardten DR, Lindstrom RL et al (1996) Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 15(5):537–540
Rubinfeld RS, Pfister RR, Stein RM et al (1992) Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 99(11):1647–1654
Kunitomo N, Mori S (1963) Studies on pterygium: Report 4. A treatment of pterygium by mitomycin C. Acta Soc Ophthalmol Jpn 67:601–607
Caliskan S, Orhan M, Irkec M (1996) Intraoperative and postoperative use of mitomycin-C in the treatment of primary pterygium. Ophthalmic Surg Lasers 27(7):600–604
Helal M, Messiha N, Amayem A et al (1996) Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium. Ophthalmic Surg Lasers 27(8):674–678
Young AL, Leung GYS, Wong AKK (2004) A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium. Br J Ophthalmol 88(8):995–997
Al Fayez MF (2002) Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 109(9):1752–1755
Rao SK, Lekha T, Mukesh BN et al (1998) Conjunctival-limbal autografts for primary and recurrent pterygia: technique and results. Ind J Ophthalmol 46(4):203–209
Barraquer JI, Binder PS, Buxton JN et al (1980) Etiology and treatment of pterygium. In: Symposium on medical and surgical diseases of the cornea. Transactions of the New Orleans Academy of Ophthalmology. St Louis: CV Mosby; 167–178
Chen PP, Ariyasu RG, Kaza V et al (1995) A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol 120(2):151–160
Kenyon KR, Tseng SCG (1989) Limbal autograft transplantation for ocular surface disorders. Ophthalmology 96(5):709–723
Gris O, Guell JL, del Campo Z (2000) Limbal-conjunctival autograft transplantation for the treatment of recurrent pterygium. Ophthalmology 107(2):270–273
Hardman JG, Limbird LE, Molinoff PB et al (1996) Goodman and Gilman’s Las Bases Farmacologicas de la Therapeutica, 9th edn. McGraw–Hill Interamericana, Mexico D.F., pp 1347–1348
Cheng HC, Tseng SH, Kao PL et al (2001) Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery. Cornea 20(1):24–29
Cardillo JA, Alves MR, Ambroso LE et al (1995) Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Ophthalmology 102(12):1949–1952
Cano-Parra J, Diaz LM, Maldonado MJ et al (1995) Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. Br J Ophthalmol 79(5):439–441
Anduze AL (2001) Pterygium surgery with mitomycin-C: ten-year results. Ophthalmic Surg Lasers 32(4):341–345
Ivekovic R, Mandie Z, Saric D et al (2001) Comparative study of pterygium surgery. Ophthalmologica 215:394–397